Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$11,075,631
+$429,781 QoQ
Shares Held
43,610
+0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.90%
of 13F equity value
Holder Rank
#1,050
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SevenBridge Financial Group, LLC holds $35,490,451 across 9 Drug Manufacturers - General names. JNJ ranks #1 (31.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
43,610 | $11,075,631 | |
| 2 | LLY |
ELI LILLY & Co
|
8,963 | $10,750,491 | |
| 3 | ABBV |
AbbVie Inc.
|
15,049 | $3,786,930 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,263 | $3,246,295 | |
| 5 | AMGN |
Amgen Inc
|
7,381 | $2,672,807 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
21,619 | $1,245,686 | |
| 7 | NVS |
Novartis AG
|
7,267 | $1,138,884 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,580 | $831,317 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,075,631 | 43,610 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $10,645,850 | 43,552 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $9,198,306 | 44,447 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $8,345,383 | 45,008 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,892,691 | 45,124 | Shares | Sole | 2025-09-04 | |
| 2025-03-31 | $7,171,584 | 43,244 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,582,668 | 45,517 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $7,490,089 | 46,218 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,648,964 | 45,491 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $7,256,808 | 45,874 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $7,151,262 | 45,625 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $7,030,555 | 45,140 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $7,577,505 | 45,780 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $7,115,430 | 45,906 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $7,981,400 | 45,182 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $7,336,660 | 44,911 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $7,498,732 | 42,244 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $7,510,652 | 42,378 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $7,902,407 | 46,194 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $7,427,223 | 45,989 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $7,496,493 | 45,505 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $7,316,368 | 44,517 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $6,847,446 | 43,509 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $5,946,713 | 39,943 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $4,987,161 | 35,463 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $4,619,316 | 35,227 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||